NCT00001992View on ClinicalTrials.gov

A Phase I Study of the Safety and Immunogenicity of Rgp 120/HIV-1IIIB Vaccine in HIV-1 Seropositive Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
BIOLOGICAL

rgp120/HIV-1IIIB

Trial Locations (1)

20850

Walter Reed Army Institute of Research, Rockville

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY